Entire Transcript in Adobe Acrobat Format - National Reference ...

65
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
that? It is 9:30 and we are supposed to go to the next
item but I want to give you a word here.
DR. EMANUEL: I think that the -- I mean, there
is a balance here and what -- I think David's general
picture is right but we recognize that there are going to
be some exceptions and tough cases. The one of you find
something either serendipitously about someone and you
might want to walk backwards. How -- there is also the
policy issue of how detailed that encryption or how that
rigorous that encryption barrier is. And I think those are
important issues.
We are trying to create a workable policy again
which can be implemented by IRB's throughout the country
and -- because I think realistically we are not going to
have -- these are not the kinds of studies that you are
going to have a RAC-like -- because there are going to be
hundreds of them throughout -- if not thousands of them
throughout the country.
We also -- I think my final comment is we need
to -- while genetics is here everywhere, I think my own
reading is there are going to be just as many studies that
are not genetic and we need to be very clear about that.
There are a lot of immunology studies. There are a lot of
studies of new factors that are not at all genetic. So we